PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1100094
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1100094
Asia-Pacific medical device testing market is projected to register a substantial CAGR of 11.7% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029.
Asia-Pacific Medical Device Testing Market, By Service Type (Testing Services, Inspection Service and Certification Services), Testing Type (Physical Testing, Chemical/Biological Testing, Cybersecurity Testing, Microbiology and Sterility Testing, and Others), Phase (Preclinical and Clinical), Sourcing Type (In-House and Outsourced), Device Class (Class I, Class II, and Class III), Product (Active Implant Medical Device, Active Medical Device, Non-active Medical Device, In-vitro Diagnostics Medical Device, Ophthalmic Medical Device, Orthopedic and Dental Medical Device, Vascular Medical Device, and Others), Country (China, India, Japan, Australia, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, and Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Due to development in AI and IoT in various medical devices
Intertek Group plc
SGS SA
Bureau Veritas
TUV SUD
TUV Rheinland
Biomedical Device Labs
UL LLC
North American Science Associates, LLC
WuXi AppTec
NSF
Eurofins Scientific
Nelson Laboratories, LLC- A Sotera Health company
Element Materials Technology
Medical Engineering Technologies Ltd.
Bioneeds
Cigniti
Arbro Pharmaceuticals Private Limited & Auriga Research Private Limited
IMR Test Labs